Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1188541014 | Lisinopril+hydrochlorothiazide 10mg/12.5mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3468181018 | Product containing lisinopril 10 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3483475010 | Product containing lisinopril 10 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3500275019 | Lisinopril 10 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3565408012 | Product containing only lisinopril 10 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3565409016 | Product containing only lisinopril 10 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680276015 | Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680277012 | Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3680278019 | Hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 462525019 | Lisinopril+hydrochlorothiazide 10mg/12.5mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 714938013 | Lisinopril+hydrochlorothiazide 10mg/12.5mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Hydrochlorothiazide and lisinopril only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Lisinopril+diuretic (product) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing hydrochlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Lisinopril (substance) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing lisinopril (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing hydrochlorothiazide and lisinopril (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Lisinopril (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 12.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 12.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Lisinopril (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Lisinopril (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Lisinopril (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR